Open AccessCompared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or anti-TNF agents: a systematic review and network
Author(s) -
Amanda Borges de Oliveira,
Alisson Pugliesi,
Ricardo Machado Xavier,
Lícia Maria Henrique da Mota,
Manoel Barros Bértolo,
Miguel Á. González-Gay,
Gustavo Citera,
Luiz Sérgio Fernandes de Carvalho
Publication year - 2021
Publication title -
sbr 2021 congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2021.1990
Subject(s) - abatacept , tocilizumab , rituximab , rheumatoid arthritis , medicine , methotrexate , refractory (planetary science) , tnf inhibitor , tumor necrosis factor alpha , antirheumatic agents , monoclonal , immunology , oncology , monoclonal antibody , adalimumab , antibody , physics , astrobiology